Education
About Us
Working with TipRanks
Follow Us
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview
14.16% Insiders
5.40% Mutual Funds
26.93% Other Institutional Investors
5.98% ETFs
47.53% Public Companies and
Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 38.31% of the company’s stock is owned by Institutional Investors, 14.16% is owned by Insiders, and 47.53% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 05, 2025 | xxxxxxxxxxxxx | $5010 | |
| Mar 05, 2025 | Justin B. Klee Co Ceo,director | xxxxxxxxxxxxx | $14474 |
| Mar 05, 2025 | Joshua B Cohen Co Ceo,director | xxxxxxxxxxxxx | $14520 |
| Feb 26, 2025 | xxxxxxxxxxxxx | $13132 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $52576 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $561810 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $25607035 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,774,348 | Institution | 7.65% | 24,557,012 | |
| 3,202,381 | Insider | 4.70% | 11,608,631 | |
| 3,376,770 | Insider | 3.81% | 12,240,791 | |
| 3,376,766 | Insider | 3.81% | 12,240,777 | |
| 3,059,188 | Institution | 3.45% | 11,089,557 | |
| 2,209,873 | Institution | 2.49% | 8,010,790 | |
| 1,150,221 | Institution | 1.30% | 4,169,551 | |
| 936,967 | Institution | 1.06% | 3,396,505 | |
| 881,370 | Institution | 0.99% | 3,194,966 | |
| 830,661 | Insider | 0.94% | 3,011,146 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,209,873 | Institution | 2.49% | 8,010,790 | |
| 782,806 | Institution | 0.88% | 2,837,672 | |
| 492,421 | Institution | 0.56% | 1,785,026 | |
| 384,510 | Institution | 0.43% | 1,393,849 | |
| 201,137 | Institution | 0.23% | 729,122 | |
| 157,412 | Institution | 0.18% | 570,619 | |
| 146,500 | Institution | 0.17% | 531,063 | |
| 145,321 | Institution | 0.16% | 526,789 | |
| 65,400 | Institution | 0.07% | 237,075 | |
| 38,707 | Institution | 0.04% | 140,313 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,161,446 | Institution | 2.44% | 7,089,543 | |
| 732,211 | Institution | 0.83% | 2,401,652 | |
| 387,802 | Institution | 0.44% | 1,310,769 | |
| 335,380 | Institution | 0.38% | 1,215,753 | |
| 331,192 | Institution | 0.37% | 1,200,571 | |
| 238,339 | Institution | 0.27% | 874,704 | |
| 189,752 | Institution | 0.21% | 622,387 | |
| 183,055 | Institution | 0.21% | 671,812 | |
| 183,055 | Institution | 0.21% | 671,812 | |
| 141,339 | Institution | 0.16% | 512,354 |
FAQ
Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
According to the latest TipRanks data, approximately 26.93% of the company's stock is held by institutional investors, 14.16% is held by insiders, and 47.53% is held by retail investors.
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.93% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors.
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.53% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors.
Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
Joseph Edelman owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.